Orient Pharma (OP), a reinvested subsidiary of the Orient EuroPharma Group (OEP), will be listed on Taiwan's over-the-counter (OTC) market in late August 2025...
The article requires paid subscription.
Subscribe Now
Orient Pharma (OP), a reinvested subsidiary of the Orient EuroPharma Group (OEP), will be listed on Taiwan's over-the-counter (OTC) market in late August 2025...